Cardinal Health(DE:CLH)
€247.80+1.30 (+0.53%)
DE:CLH
Cardinal Health stock forecast
€247.80
At close:+1.30 (+0.53%)
Cardinal Health (CLH) Stock Forecast & Price Target
3 Followers
CLH Analyst Ratings
Strong Buy
11Buy2Hold0Sell
Based on 13 analysts giving stock ratings to Cardinal Health in the past 3 months
CLH Stock 12 Month Forecast
Average Price Target
€263.98▲(6.53% Upside)Based on 13 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is EUR 263.98 with a high forecast of EUR 288.38 and a low forecast of EUR 235.21. The average price target represents a 6.53% change from the last price of EUR 247.80.
Past 12 Months12 Month ForecastJan2026Oct2026
High€288.38
Average€263.98
Low€235.21
Highest Price TargetHighest€288.38Average Price Target€263.98Lowest Price TargetLowest€235.21
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Steven Silver | Argus Research | €237.91→€278.46 | buy | 12.37%Upside | Reiterated | 11/11/26 | ||
| Lisa Gill | J.P. Morgan | €234.31→€257.74 | hold | 4.01%Upside | Reiterated | 11/10/26 | ||
| Allen Lutz | Bank of America Securities | €288.38 | buy | 16.38%Upside | Reiterated | 11/10/26 | ||
| Charles Rhyee | TD Cowen | €252.33→€273.96 | buy | 10.56%Upside | Assigned | 11/09/26 | ||
| Glen Santangelo | Barclays | €247.82 | buy | <0.01%Upside | Reiterated | 11/06/26 | ||
| Erin Wright | Morgan Stanley | €257.74→€275.76 | buy | 11.28%Upside | Assigned | 11/06/26 | ||
| Kevin Caliendo | UBS | €265.85→€279.37 | buy | 12.74%Upside | Reiterated | 11/06/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | €243.32 | buy | -1.81%Downside | Reiterated | 11/05/26 | ||
| Eric Coldwell | Robert W. Baird | €248.73→€274.86 | buy | 10.92%Upside | Reiterated | 11/05/26 | ||
| Steven Valiquette | Mizuho Securities | €252.33→€261.34 | buy | 5.46%Upside | Reiterated | 11/05/26 | ||
| Ryan Halsted | RBC Capital | €248.73→€265.85 | buy | 7.28%Upside | Assigned | 11/05/26 | ||
| Stephen Baxter | Wells Fargo | €249.63 | buy | 0.74%Upside | Reiterated | 09/09/26 | ||
| George Hill | Deutsche Bank | €200.96→€235.21 | hold | -5.08%Downside | Reiterated | 08/13/26 | ||
| Daniel Grosslight | Citi | €238.81→€252.33 | buy | 1.83%Upside | Reiterated | 08/12/26 | ||
| Ryan Daniels | William Blair | ― | buy | ― | Reiterated | 08/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Steven SilverArgus Research | BuyReiterated€237.91→€278.46 | 11/11/26 | 12.37%Upside | ||
| Lisa GillJ.P. Morgan | HoldReiterated€234.31→€257.74 | 11/10/26 | 4.01%Upside | ||
| Allen LutzBank of America Securities | BuyReiterated€288.38 | 11/10/26 | 16.38%Upside | ||
| Charles RhyeeTD Cowen | BuyAssigned€252.33→€273.96 | 11/09/26 | 10.56%Upside | ||
| Glen SantangeloBarclays | BuyReiterated€247.82 | 11/06/26 | <0.01%Upside | ||
| Erin WrightMorgan Stanley | BuyAssigned€257.74→€275.76 | 11/06/26 | 11.28%Upside | ||
| Kevin CaliendoUBS | BuyReiterated€265.85→€279.37 | 11/06/26 | 12.74%Upside | ||
| Elizabeth Anderson CFAEvercore ISI | BuyReiterated€243.32 | 11/05/26 | -1.81%Downside | ||
| Eric ColdwellRobert W. Baird | BuyReiterated€248.73→€274.86 | 11/05/26 | 10.92%Upside | ||
| Steven ValiquetteMizuho Securities | BuyReiterated€252.33→€261.34 | 11/05/26 | 5.46%Upside | ||
| Ryan HalstedRBC Capital | BuyAssigned€248.73→€265.85 | 11/05/26 | 7.28%Upside | ||
| Stephen BaxterWells Fargo | BuyReiterated€249.63 | 09/09/26 | 0.74%Upside | ||
| George HillDeutsche Bank | HoldReiterated€200.96→€235.21 | 08/13/26 | -5.08%Downside | ||
| Daniel GrosslightCiti | BuyReiterated€238.81→€252.33 | 08/12/26 | 1.83%Upside | ||
| Ryan DanielsWilliam Blair | BuyReiterated | 08/11/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cardinal Health
3 Months
Success Rate12/14 ratings generated profit
86%
Average Return
+10.94%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +10.94% per trade.
1 Year
Success Rate14/14 ratings generated profit
100%
Average Return
+34.54%
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +34.54% per trade.
2 Years
Success Rate21/21 ratings generated profit
100%
Average Return
+73.69%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +73.69% per trade.
CLH Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 16 | 20 | 19 | 18 | 17 |
| Hold | 1 | 4 | 4 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 17 | 24 | 23 | 22 | 18 |
In the current month, CLH has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 263.98.
CLH Financial Forecast
High€3.26
Consensus€2.81
Low€2.62
CLH Earnings Forecast
Next quarter’s earnings estimate for CLH is EUR 2.81 with a range of EUR 2.62 to EUR 3.26. The previous quarter’s EPS was EUR 2.92. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€62B
Consensus€61.2B
Low€60.2B
CLH Sales Forecast
Next quarter’s sales forecast for CLH is EUR 61.17B with a range of EUR 60.24B to EUR 61.98B. The previous quarter’s sales results were EUR 60.45B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CLH Stock Forecast FAQ
What is DE:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is €263.98.
What is DE:CLH’s upside potential, based on the analysts’ average price target?
Cardinal Health has 6.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cardinal Health a Buy, Sell or Hold?
Cardinal Health has a consensus rating of Strong Buy, which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cardinal Health’s share price target?
The average share price target for Cardinal Health is €263.98. This is based on 13 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €288.38, and the lowest forecast is €235.21. The average share price target represents a 6.53% increase from the current price of €247.8.
What do analysts say about Cardinal Health?
Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Street analysts.
How can I buy shares of Cardinal Health?
To buy shares of DE:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
